Through years of hard work, we have accumulated industry-leading expertise in the fields of molecular design and PK / PD modeling. Through existing R & D platforms, especially new technologies such as PROTAC (Protein Degradation Targeting Chimera), we are exploring the pharmaceutical Continued research and exploration in areas of concern such as tumors and skin diseases to meet the needs of patients worldwide.